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Objective: To assess the efficacy of low-dose Cidofovir in the treat-
ment of BK virus associated nephropathy.
Method: Two adult kidney transplant recipients with biopsy-proven
BK nephropathy and persistent high viremia (>10,000 copies/ml)
despite 3-month reduction of immunosuppressive therapy were
treated by Cidofovir 0.5 mg/kg fortnightly for a total of 16 weeks
(8 doses). Clinical response was assessed by following BK viremia.
Results: No decrease in BK viremia was observed at any point dur-
ing cidofovir therapy (see figure). Creatinine clearance remained
stable during therapy and no side-effects of Cidofovir were ob-
served.
Conclusions: Low-dose Cidofovir therapy was not associated with
a clearance or with a significant decrease of BK viremia. This pilot
study does not confirm previous reports suggesting clinical efficacy
of Cidofovir for BK virus associated nephropathy.
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Background: Cytomegalovirus (CMV) disease remains an important
cause of morbidity after kidney transplantation and has been asso-
ciated with acute rejection, graft loss and other indirect effects.
A 3-month course of VGC prophylaxis reduces the incidence of CMV
disease. However, little is known about the indirect effects of late-
onset CMV disease after VGC prophylaxis.
Objective: To evaluate the impact and indirect consequences of
late-onset CMV disease after VGC prophylaxis in kidney transplant
recipients.
Methods: Retrospective analysis of 61 consecutive adult kidney
transplant recipient with positive CMV serology (donor or recipi-
ent) who received VGC prophylaxis for 3 months and completed
a follow-up of at least 2 years post-transplantation. Patients who
developed CMV disease within 1 year after transplantation were
compared to CMV disease-free patients for renal function (plasma
creatinine values) at 1, 6, 12 and 24 months and for the incidence
of graft loss, acute rejection, diabetes, cancer and opportunistic
infections.
Results: 8/61 (13%) patients developed CMV disease at a median of
131 days after transplantation (range: 98–220). The CMV incidence
in D+/R- high risk patients was 6/18 (33%), while it was 2/43 (5%) in
intermediate-risk patients (p < 0.01). All 8 patients were treated
by oral valganciclovir (median 39 days; range: 19–119) with a com-
plete resolution of CMV disease. As shown in the figure, there was
no difference in creatinine values between the two groups at any
time during follow-up. There was no graft loss, and the incidence
of acute rejection, cancer and opportunistic infections did not dif-
fer between the two groups. The incidence of post-transplant di-
abetes was higher (38% vs 15%) in patients with CMV disease, but
this difference was not significant (p = 0.4).
Conclusions: An incidence of 13% of late-onset CMV disease was
observed despite 3 months VGC prophylaxis. However, no indirect
consequences were found. Moreover, therapy of CMV disease by
oral VGC was effective and safe. Larger trials are needed to study
whether late-onset CMV disease is associated with indirect conse-
quences, as described with early-onset CMV.
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Background: BKV associated nephropathy is a major problem
among renal transplant recipients as it leads to graft loss. Iden-
tification and monitoring of high risk patients is crucial for the
induction of therapy and the survival of the graft.
Objectives: We examine the effectiveness of quantitative Real-
Time PCR to identify patients at high risk of BKVN and monitor the
efficacy of treatment, in order to avoid invasive methods.
Methods: From 7/2005 to 2/2008 231 paired samples (plasma and
urine) were sent to our lab for BKV viral load measurement. The
samples were drawn upon kidney dysfunction from 121 patients
that underwent renal transplantation at the transplant unit of
Laiko Hospital. On the basis of PCR positivity the patients were
classified into 3 groups. Group 1 (n=89) tested negative both in
plasma and urine. In Group 2 (n=22) BKV DNA was detected only in
urine while Group 3 patients (n=10) had DNAemia and viruria and
were treated with leflunomide along with reduction of immuno-
suppression.
Results: Group 1 and Group 2 patients never developed BKVN.
Group 2 patients had a median viral load of 2.6×104 copies/mL,
but had negative urine cytopathology or biopsy. Group 3 me-
dian viral load of DNAemia and viruria was respectively 3.9×104
copies/mL and 7.15×104 copies/mL. 80% of the patients had posi-
tive urine cytopathology and 100% had positive biopsy.
Upon treatment with leflunomide DNAemia resolved very quickly,
while viruria showed clearance or progressive reduction in 80%.
Two patients that showed multiple reactivations of the virus even-
tually resolved as well.
Conclusions: Viral load measurement in paired plasma and urine
samples is a sensitive and specific non invasive method for the
monitoring of BKV infection in RT recipients. Since the incidence of
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BKVN is 8.3% the method is also cost-effective. Leflunomide treat-
ment seems to be effective for the clearance of BKVN.
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Background: Intestinal transplantation has emerged as a treat-
ment option for patients with life-threatening intestinal failure.
The most common complication and cause of death is infection.
Objective: To determine the 6 month post-operative incidence of
bloodstream infections (BSI), and to characterize associated risk
factors.
Material and Methods: We performed a retrospective chart review
of all small bowel transplant recipients between 2003 -2007. The
characteristics below were analyzed as potential risk factors for
BSI: colon/liver inclusion, total bilirubin >5, surgical complica-
tions, & acute rejection. Most patients received immunosuppres-
sion with basiliximab, tacrolimus, sirolimus and a prednisone taper.
6 patients received thymoglobulin instead of basiliximab.
Results: Fifty-six patients received an intestinal transplant from
November 2003 to July 2007. Twenty-three were adult (>18
years), and 33 pediatric. Nine adults and 25 children developed
BSI (p=0.006). Twenty-two patients received an isolated intesti-
nal transplant, 16 liver-intestine, 16 multivisceral, and 2 modi-
fied multivisceral. The patient characteristics are listed in table
1. Thirty-four of 56 patients (61%) had at least one episode of BSI.
A total of 85 episodes of BSI were observed, with 65.9% of BSI due
to Gram-positives, 34.1% Gram-negatives and 2.4% fungemia (table
2). The most common isolates were: VRE/non-VRE, Enterobacter,
Klebsiella and coagulase negative Staphylococci. The mean time to
first BSI was 26.4 days. Of 85 BSI episodes, 69 occurred in patients
who received a liver. In these 32 patients, 23 had BSI compared
to 11 of the 24 non-liver patients (p=0.048) (table 3). Of 27 pa-
tients with a total bilirubin >5mg/dL, 21 developed BSI compared
to 9 of the 29 patients with a total bilirubin ≤5mg/dL (p=0.000).
Severn of 11 colon inclusion patients developed BSI compared to
27/45 non-colon inclusion pts (p=ns). Of 21 patients with surgical
complications, 12 developed BSI versus 21 of the 35 patients with-
out complications (p=ns). Nineteen patients had acute rejection.
Twelve of these patients had BSI compared to 23 of the 37 patients
who did not reject (p=ns).
Table 1. Patient characteristics
Total number of patients 56
Adults / Pediatric 23 / 33
Males / Female 32 / 24
Average Age ± SD 18.4±19.8 yrs
Age range 6 months – 62 years
Colon inclusion 11 pts
Liver inclusion 32 pts
Surgical complications (perforation, leak, bleed, abscess) 21
Patients with acute rejection 19 pts
Abstract 30 – Table 2. Microbiology of BSI episodes
Organism Overall Colon +/– liver Non-colon +/– liver Liver
(n = 85 episodes) (n = 17 episodes) (n = 68 episodes) (n = 69 episodes)
Gram-positive cocci 56/85 12/17 44/68 49/69
(VRE, CNS, MRSA, MSSA, Strep viridans) (65.9%) (70.6%) (64.7%) (71.0%)
Gram-neg rods (Enterobacter, Klebsiella, 29/85 5/17 24/68 20/69
Pseudomonas, E .coli, Citrobacter, others**) (34.1%) (29.4%) (35.3%) (29.0%)
Candida species 2/85 1/17 1/68 2/69
(C. albicans, C. parapsilosis) (2.4%) (5.9%) (1.5%) (2.9%)
**Burkholderia, Stenotrophomonas, Serratia, Capnocytophaga.
Table 3. Patient variables and incidence of BSI
Variable Number of Number of p value
Pts Pts with BSI
Age (Pediatric vs. Adult) 33 / 23 25/9 0.006
Colon (Inclusion vs. No Inclusion) 11 / 45 7/27 ns
Liver (Inclusion vs. No Inclusion) 32 / 24 23/11 0.048
Total bilirubin at Tx (>5 vs ≤5) 27 / 29 21/9 0.000
Surgical complications (Present vs. Absent) 21 / 35 12/21 ns
Acute rejection (Present vs. Absent) 19 / 37 12/23 ns
Conclusions: BSI are a common complication of intestinal trans-
plant. The incidence appears to be higher in children. It appears
that liver inclusion and preoperative bilirubin >5 are associated
with a higher incidence of BSI. Acute rejection and colon inclusion
do not appear to have an influence on BSI incidence.
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The Utility of Surveillance Bronchoscopy for the Detection
of Subclinical Infection after Lung Transplantation
Kimberly Hanson, Sylvia Costa, Barbara Alexander. Duke
University Medical Center Departments of Medicine and
Pathology Durham, NC 27710 USA
Background: Surveillance bronchoscopy is often performed after
lung transplantation in an attempt to identify acute rejection or in-
fection before signs of disease develop. This practice is not known
to improve outcomes.
Objective: To evaluate the microbiologic yield of surveillance BAL
in lung transplant recipients during the first year post-transplant.
Methods: Medical records for all adults who underwent lung trans-
plantation at Duke University between 01 Jan 2005 and 01 Jan
2007 were reviewed. Surveillance bronchoscopies were performed
1, 3, 6 and 12 months after transplant. If acute rejection was de-
tected, the procedure was repeated monthly until 2 sequential
biopsies were negative. BAL specimens were classified according
to whether the subject had symptoms (i.e. new or worsening dysp-
nea, cough, sputum production, fever, a decrease in lung function,
or chest radiograph changes). The clinical relevance of microor-
ganisms detected by culture, direct fluorescent antibody [DFA] or
stain was determined and all therapeutic interventions recorded.
Results: During the study period 128 transplants (124 double-lung,
3 single-lung, and 1 heart-lung) were performed. The median
(range) subject age was 55 (17-70) years. The most common
conditions necessitating transplant were idiopathic pulmonary hy-
pertension (n=42), COPD (n=36), and cystic fibrosis (n=18). A total
of 630 surveillance BALs were submitted for microbiologic analysis;
28.7% (181/630) were from subjects with documented symptoms.
Most (67.5% [425/630]) surveillance samples grew only oropharyn-
geal flora and 4.9% (31/630) were completely negative. Overall,
27.9% (176/630) of specimens had a potential pathogen detected.
Of the potentially significant organisms identified, bacteria
accounted for 41.4% (72/174), fungi 21.8% (38/174), viruses 21.2%
(37/174), mycobacteria 7.5% (13/174), and PCP 1.1% (2/174).
Multiple pathogens were found in 14 samples. BAL fluid from symp-
tomatic subjects yielded a potential pathogen more often than
